Search

Your search keyword '"Chirivella, Isabel"' showing total 4 results
Start Over Author "Chirivella, Isabel" Journal european urology oncology
4 results on '"Chirivella, Isabel"'

1. Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

Author

Jiménez, Natalia, Garcia de Herreros, Marta, Reig, Òscar, Marín-Aguilera, Mercedes, Aversa, Caterina, Ferrer-Mileo, Laura, García-Esteve, Samuel, Rodríguez-Carunchio, Leonardo, Trias, Isabel, Font, Albert, Rodriguez-Vida, Alejo, Climent, Miguel Ángel, Cros, Sara, Chirivella, Isabel, Domènech, Montserrat, Figols, Mariona, Carles, Joan, Suárez, Cristina, Herrero Rivera, Daniel, González-Billalabeitia, Enrique, Cívico, Claudia, Sala-González, Núria, Ruiz de Porras, Vicenç, Ribal, Maria J., Prat, Aleix, and Mellado, Begoña

Published
2024
Full Text
View/download PDF

2. Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

Author

Romero-Laorden, Nuria, Lorente, David, de Velasco, Guillermo, Lozano, Rebeca, Herrera, Bernardo, Puente, Javier, López, Pedro P., Medina, Ana, Almagro, Elena, Gonzalez-Billalabeitia, Enrique, Villla-Guzman, Jose Carlos, González-del-Alba, Aránzazu, Borrega, Pablo, Laínez, Nuria, Fernández-Freire, Ana, Hernández, Amaia, Rodriguez-Vida, Alejo, Chirivella, Isabel, Fernandez-Parra, Eva, López-Campos, Fernando, Isabel Pacheco, Maria, Morales-Barrera, Rafael, Fernández, Ovidio, Villatoro, Rosa, Luque, Raquel, Hernando, Susana, Castellano, Daniel C., Castro, Elena, and Olmos, David

Published
2024
Full Text
View/download PDF

3. Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

Author

Romero-Laorden, Nuria, primary, Lorente, David, additional, de Velasco, Guillermo, additional, Lozano, Rebeca, additional, Herrera, Bernardo, additional, Puente, Javier, additional, López, Pedro P., additional, Medina, Ana, additional, Almagro, Elena, additional, Gonzalez-Billalabeitia, Enrique, additional, Villla-Guzman, Jose Carlos, additional, González-del-Alba, Aránzazu, additional, Borrega, Pablo, additional, Laínez, Nuria, additional, Fernández-Freire, Ana, additional, Hernández, Amaia, additional, Rodriguez-Vida, Alejo, additional, Chirivella, Isabel, additional, Fernandez-Parra, Eva, additional, López-Campos, Fernando, additional, Isabel Pacheco, Maria, additional, Morales-Barrera, Rafael, additional, Fernández, Ovidio, additional, Villatoro, Rosa, additional, Luque, Raquel, additional, Hernando, Susana, additional, Castellano, Daniel C., additional, Castro, Elena, additional, and Olmos, David, additional

Published
2023
Full Text
View/download PDF

4. Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN,and TP53in Metastatic Hormone-sensitive Prostate Cancer Patients

Author

Jiménez, Natalia, Garcia de Herreros, Marta, Reig, Òscar, Marín-Aguilera, Mercedes, Aversa, Caterina, Ferrer-Mileo, Laura, García-Esteve, Samuel, Rodríguez-Carunchio, Leonardo, Trias, Isabel, Font, Albert, Rodriguez-Vida, Alejo, Ángel Climent, Miguel, Cros, Sara, Chirivella, Isabel, Domènech, Montserrat, Figols, Mariona, Carles, Joan, Suárez, Cristina, Herrero Rivera, Daniel, González-Billalabeitia, Enrique, Cívico, Claudia, Sala-González, Núria, Ruiz de Porras, Vicenç, Ribal, Maria J., Prat, Aleix, and Mellado, Begoña

Abstract

Low mRNA expression of two or more of the tumor suppressor genes (TSGs) RB1, PTEN, and TP53correlated with adverse outcomes in patients with metastatic hormone-sensitive prostate cancer. These results were validated independently in the CHAARTED trial dataset. No interaction was observed between TSG signature and treatment.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results